2016 - Contraceptive Technology Boston

U.S. Selected Practice Recommendations: What Does the Evidence Say About Handling Challenging or Controversial Contraceptive Management Questions? (Rx = .75 hr.)

Apr 24, 2016 9:30am ‐ Apr 24, 2016 10:15am

Expiration Date: May 12, 2019


Credits: None available.

Standard: $15.00

Description

Learning Objectives:

  • Describe the contents of US SPR and its intended use
  • Describe how to use the US SPR, including using any associated tools
  • Apply the guidance in specific situations, based on clinical scenarios

Speaker(s):

Disclosures

  • Patty Cason, MS, FNP-BC:

    Disclosure:

    Merck
    Teva
    Actavis, Medicines 360
    Bayer
    ContraMed
    Evofem

    Relationship:

    Trainer Speaker Advisory Board
    Consultant
    Trainer Speaker
    Consultant, Advisory Board
    Consultant, Trainer
    Advisory Board

  • Melissa Kottke, MD, MPH:

    Disclosure:

    Merck
    CSL Behring

    Relationship:

    Faculty Trainer
    Consultant

  • Emily Godfrey, MD, MPH:

    Disclosure:

    Merck
    Merck
    Teva
    Bayer
    Prima-temp

    Relationship:

    Trainer
    Research
    Research
    Research
    Research

Credits

  • 0.75 - Pharmacology
  • 1.25 - Physician
  • 1.25 - RN / NP (All RNs/Nurses except CA RNs)
  • 1.25 - CA RN/CA BRN

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content